Evidence that HLA-DQ9 confers risk to celiac disease by presence of DQ9-restricted gluten-specific T cells

Human Immunology

Volumn 73, Issue 4, 2012, Pages 376-381

  Bodd, Michael ^a   Tollefsen, Stig ^a   Bergseng, Elin ^b   Lundin, Knut E A ^a   Sollid, Ludvig M ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Celiac disease; DQ8 glut 1 epitope; HLA DQ 57; HLA DQ9; MHC

Indexed keywords

EPITOPE; GAMMA INTERFERON; GLIADIN; GLUTAMIC ACID; GLUTEN; GLUTENIN; HLA DQ ANTIGEN; HLA DQ9 ANTIGEN; PEPSIN A; TRYPSIN; UNCLASSIFIED DRUG;

ADULT; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CASE REPORT; CELIAC DISEASE; CYTOKINE RELEASE; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FOLLOW UP; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GLUTEN FREE DIET; HAPLOTYPE; HETEROZYGOTE; HISTOPATHOLOGY; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; INTESTINE BIOPSY; LYMPHOCYTE CLONE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; CELIAC DISEASE; EPITOPES, T-LYMPHOCYTE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTAMIC ACID; GLUTAMINE; GLUTENS; HLA-DQ ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING; RISK; T-LYMPHOCYTES;

EID: 84859104989     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.01.016     Document Type: Article

References (21)

1. Todd J.A., Bell J.I., McDevitt H.O. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987, 329:599-604.
2. Hovhannisyan Z., Weiss A., Martin A., Wiesner M., Tollefsen S., Yoshida K., et al. The role of HLA-DQ8 β57 polymorphism in the anti-gluten T-cell response in coeliac disease. Nature 2008, 456:534-538.
3. Lee K.H., Wucherpfennig K.W., Wiley D.C. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat Immunol 2001, 2:501-507.
4. Kwok W.W., Domeier M.E., Johnson M.L., Nepom G.T., Koelle D.M. HLA-DQB1 codon 57 is critical for peptide binding and recognition. J Exp Med 1996, 183:1253-1258.
5. Moustakas A.K., van de Wal Y., Routsias J., Kooy Y.M., van Veelen P.A., Drijfhout J.W., et al. Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes. Int Immunol 2000, 12:1157-1166.
6. Molberg Ø., Kett K., Scott H., Thorsby E., Sollid L.M., Lundin K.E. Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls. Scand J Immunol 1997, 46:103-108.
7. Molberg Ø., McAdam S.N., Körner R., Quarsten H., Kristiansen C., Madsen L., et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998, 4:713-717.
8. Kagnoff M.F. AGA institute medical position statement on the diagnosis and management of celiac disease. Gastroenterology 2006, 131:1977-1980.
9. Ráki M., Fallang L.E., Brottveit M., Bergseng E., Quarsten H., Lundin K.E., et al. Tetramer visualization of gut-homing gluten-specific T cells in the peripheral blood of celiac disease patients. Proc Natl Acad Sci U S A 2007, 104:2831-2836.
10. Anderson R.P., van Heel D.A., Tye-Din J.A., Barnardo M., Salio M., Jewell D.P., et al. T cells in peripheral blood after gluten challenge in coeliac disease. Gut 2005, 54:1217-1223.
11. Molberg Ø., McAdam S.N., Lundin K.E., Sollid L.M. Studies of gliadin-specific T cells in celiac disease. Celiac disease methods and protocols 2000, 105-124. Humana, Totowa, NJ. M.N. Marsh (Ed.).
12. Fallang L.E., Bergseng E., Hotta K., Berg-Larsen A., Kim C.Y., Sollid L.M. Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation. Nat Immunol 2009, 10:1096-1101.
13. Jüse U., Arntzen M., Højrup P., Fleckenstein B., Sollid L.M. Assessing high affinity binding to HLA-DQ2.5 by a novel peptide library based approach. Bioorg Med Chem 2011, 19:2470-2477.
14. Vader W., Stepniak D., Kooy Y., Mearin L., Thompson A., van Rood J.J., et al. 2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci U S A 2003, 100:12390-12395.
15. van de Wal Y., Kooy Y.M., van Veelen P.A., Vader W., August S.A., Drijfhout J.W., et al. Glutenin is involved in the gluten-driven mucosal T cell response. Eur J Immunol 1999, 29:3133-3139.
16. Klitz W., Maiers M., Spellman S., Baxter-Lowe L.A., Schmeckpeper B., Williams T.M., et al. New HLA haplotype frequency reference standards: High-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans. Tissue Antigens 2003, 62:296-307.
17. Karell K., Louka A.S., Moodie S.J., Ascher H., Clot F., Greco L., et al. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: Results from the European Genetics Cluster on Celiac Disease. Hum Immunol 2003, 64:469-477.
18. Tosi R., Tanigaki N., Polanco I., De Marchi M., Woodrow J.C., Hetzel P.A. A radioimmunoassay typing study of non-DQw2-associated celiac disease. Clin Immunol Immunopathol 1986, 39:168-172.
19. Lundin K.E., Scott H., Fausa O., Thorsby E., Sollid L.M. T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum Immunol 1994, 41:285-291.
20. Spurkland A., Sollid L.M., Polanco I., Vartdal F., Thorsby E. HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non-DR5/7. Hum Immunol 1992, 35:188-192.
21. Henderson K.N., Tye-Din J.A., Reid H.H., Chen Z., Borg N.A., Beissbarth T., et al. A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease. Immunity 2007, 27:23-34.